Keyphrases
Intensity-modulated Radiation Therapy
100%
Advanced Esophageal Cancer
100%
Proton Beam Therapy
100%
Total Toxicity
45%
Progression-free Survival
36%
Adverse Events
27%
Interim Analysis
27%
Postoperative Complications
18%
Clinical Outcomes
9%
Histology
9%
Esophageal Cancer
9%
Randomized Trial
9%
Overall Survival Rate
9%
Induction Chemotherapy
9%
Posterior Probability
9%
Accruals
9%
Resectability
9%
Esophagectomy
9%
Dosimetric
9%
Posterior Mean
9%
Passive Scattering
9%
Composite Score
9%
Group Sequential Design
9%
Stopping Boundary
9%
Complication Score
9%
Event Severity
9%
Highest Density Interval
9%
Medicine and Dentistry
Esophageal Cancer
100%
Intensity Modulated Radiation Therapy
100%
Proton Therapy
100%
Progression Free Survival
36%
Adverse Event
27%
Interim Analysis
27%
Postoperative Complication
18%
Survival Rate
18%
Overall Survival
9%
Induction Chemotherapy
9%
Esophagectomy
9%
Pharmacology, Toxicology and Pharmaceutical Science
Esophagus Cancer
100%
Progression Free Survival
100%
Adverse Event
75%
Survival Rate
50%
Postoperative Complication
50%
Chemotherapy
25%
Overall Survival
25%